The government has tightened its regulation of cough syrup sales as a safety measure. But for a lasting solution to the wanton flouting of drug retailing rules, India must relieve people of high medical costs. It’s time to invest heavily in public healthcare. For the full story, visit the source.
Politics
India needs an action plan to tackle its blurry line between over-the-counter and prescription drugs
The government has tightened its regulation of cough syrup sales as a safety measure. But for a lasting solution to the wanton flouting of drug retailing rules, India must relieve people of high medical costs. It’s time to invest heavily in public healthcare.
By Mint Editorial Board· Livemint· 4 months ago· 2 min read
This summary is sourced from Livemint. Read the full article at:Livemint